Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profitSanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit
    SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backingSETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing
    Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage studyBiohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study
    Roche secures CE Mark for Accu-Chek SugarView app for diabetes managementRoche secures CE Mark for Accu-Chek SugarView app for diabetes management
    Dr Reddys unveils generic Deferasirox Tablets in USDr Reddys unveils generic Deferasirox Tablets in US
    With Vildagliptin off-patent from today, new doors open for pharma playersWith Vildagliptin off-patent from today, new doors open for pharma players
    Sanofi to acquire biotech firm Synthorx for USD 2.5 billionSanofi to acquire biotech firm Synthorx for USD 2.5 billion
    JnJ CEO declines to appear at US congressional hearing on carcinogen in baby powderJnJ CEO declines to appear at US congressional hearing on carcinogen in baby powder
    Grifols Alzheimers trial shows positive resultsGrifols Alzheimers trial shows positive results
    Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigationSun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation
    Solara Active Pharma names Bharath R Sesha as new CEOSolara Active Pharma names Bharath R Sesha as new CEO
    Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approvalAmgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok